Reports
Sale
Global Legionella Testing Market Size, Trends, Growth, Report: By Type: Culture Methods, UAT, Serology, DFA Test, Nucleic Acid-Based Detection, PCR; By Test: Water Testing, IVD Testing; By End User: Hospital & Clinics, Others; Regional Analysis; Patent Analysis; Grants Analysis; Clinical Trials Analysis; Supplier Landscape; 2023-2031
Global Legionella Testing Market Outlook
The global legionella testing market size attained a value of USD 288.1 million in 2022. The market is likely to grow at a CAGR of 8.20% during the forecast period of 2023-2031 to attain a value of USD 585.6 million by 2031.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Growing Prevalence of Legionella in Potable Water During the COVID-19 Crisis Augmenting the Market Growth
The market for legionella testing is being aided by the growing prevalence of legionella outbreaks in various buildings, such as hotels, cruise ships, and hospitals. As the COVID-19 infection caused by the novel SARS-CoV-2 was similar to Legionnaires’ disease, mostly affecting people with weak immune systems, the demand for legionella testing significantly surged. The shutdown of manufacturing operations and businesses for an extended period of time due to the implementation of government-mandated lockdowns during the pandemic led to the stagnancy of potable water, due to which the demand for legionella testing increased to prevent the risk of Legionnaires’ disease among the employees and consumers, therefore augmenting the market growth. The trend is expected to continue in the forecast period owing to the resurgence of the virus and constant mutation of SARS-CoV-2, leading to more fatal outcomes, which is projected to propel the market growth.
Legionella Testing: Market Segmentation
Legionella testing refers to the test that detects the presence of legionella bacteria or antigen in humans and water bodies. It is essential in hot and stagnant water to prevent the risk of legionella outbreak, which can potentially be fatal to high-risk individuals. Legionella testing is typically done by deploying antigen and molecular testing methods, in which a sample of urine or sputum is collected to be analysed in a laboratory.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The major application segments of legionella testing are:
- Water Testing
- Microbial Culture
- DFA Stain
- PCR
- Others
- IVD Testing
- Blood Culture
- Urine Antigen Test
- DFA Stain
- PCR
- Others
The EMR report looks into the regional markets of legionella testing like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Rising Demand for Water Treatment to Bolster the Growth of the Legionella Testing Industry
The increasing prevalence of various microbes in water that can lead to adverse health issues is surging the demand for water treatment. This is also increasing the presence of legionella that can colonise artificial water systems and equipment, hence surging the demand for managing potable water. Hence, the growing demand for legionella testing in public-accessed buildings, fountains, care facilities and hospitals, and cooling towers, is propelling the market growth. In addition, the introduction of various initiatives by both governments and organisations to increase awareness regarding the risk of legionella growth is further augmenting the industry growth. For instance, the United Kingdom government instructed all businesses and other services to initiate vital checks such as legionella testing to prevent the risk of Legionnaires’ disease in March 2021. Such initiatives are projected to bolster the market growth in the upcoming years.
Key Industry Players in the Global Legionella Testing Market
The report presents a detailed analysis of the following key players in the global legionella testing market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Abbott Laboratories
- Alere Inc.
- Becton, Dickinson and Company (BD)
- Bio-Rad Laboratories, Inc.
- bioMerieux S.A.
- Others
The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2022 |
| Historical Period | 2016-2022 |
| Forecast Period | 2023-2031 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Test |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Legionnaires disease Overview
3.1 Guidelines and Stages
3.2 Pathophysiology
3.3 Screening and Diagnosis
3.4 Treatment Pathway
4 Patient Profile
4.1 Patient Profile Overview
4.2 Patient Psychology and Emotional Impact Factors
4.3 Risk Assessment and Treatment Success Rate
5 Diabetes Epidemiology Analysis
5.1 Epidemiology Overview (2016-2031)
5.2 North America Legionnaires Epidemiology (2016-2031)
5.3 Europe Legionnaires Epidemiology (2016-2031)
5.4 Asia-Pacific Legionnaires Epidemiology (2016-2031)
5.5 Latin America Legionnaires Epidemiology (2016-2031)
5.6 Middle East & Africa Legionnaires Epidemiology (2016-2031)
6 Global Legionella Testing Market Overview
6.1 Global Legionella Testing Market Historical Value (2016-2022)
6.2 Global Legionella Testing Market Forecast Value (2023-2031)
7 Global Legionella Testing Market Landscape
7.1 Global Legionella Testing Developers Landscape
7.1.1 Analysis by Year of Establishment
7.1.2 Analysis by Company Size
7.1.3 Analysis by Region
7.2 Global Legionella Testing Product Landscape
7.2.1 Analysis by Type
7.2.2 Analysis by Test
7.2.3 Analysis by End User
8 Legionella Testing Challenges and Unmet Needs
8.1 Treatment Pathway Challenges
8.2 Compliance and Drop-Out Analysis
8.3 Awareness and Prevention Gaps
9 Cost of Treatment
10 Global Legionella Testing Market Dynamics
10.1 Market Drivers and Constraints
10.2 SWOT Analysis
10.3 Porter’s Five Forces Model
10.4 Key Demand Indicators
10.5 Key Price Indicators
10.6 Industry Events, Initiatives, and Trends
10.7 Value Chain Analysis
11 Global Legionella Testing Market Segmentation
11.1 Global Legionella Testing Market by Type
11.1.1 Market Overview
11.1.2 Culture Methods
11.1.3 UAT
11.1.4 Serology
11.1.5 DFA Test
11.1.6 Nucleic Acid-Based Detection
11.1.7 PCR
11.2 Global Legionella Testing Market by Test
11.2.1 Market Overview
11.2.2 Water Testing
11.2.2.1 Microbial Culture
11.2.2.2 DFA Stain
11.2.2.3 PCR
11.2.2.4 Others
11.2.2.5 Others
11.2.3 IVD Testing
11.2.3.1 Blood Culture
11.2.3.2 Urine Antigen Test
11.2.3.3 DFA Stain
11.2.3.4 PCR
11.2.3.5 Others
11.3 Global Legionella Testing Market by End User
11.3.1 Market Overview
11.3.2 Hospital & Clinics
11.3.3 Diagnostic Laboratories
11.4 Global Legionella Testing Market by Region
11.4.1 Market Overview
11.4.2 North America
11.4.3 Europe
11.4.4 Asia Pacific
11.4.5 Latin America
11.4.6 Middle East and Africa
12 North America Legionella Testing Market
12.1 Market Share by Country
12.2 United States of America
12.3 Canada
13 Europe Legionella Testing Market
13.1 Market Share by Country
13.2 United Kingdom
13.3 Germany
13.4 France
13.5 Italy
13.6 Others
14 Asia Pacific Legionella Testing Market
14.1 Market Share by Country
14.2 China
14.3 Japan
14.4 India
14.5 ASEAN
14.6 Australia
14.7 Others
15 Latin America Legionella Testing Market
15.1 Market Share by Country
15.2 Brazil
15.3 Argentina
15.4 Mexico
15.5 Others
16 Middle East and Africa Legionella Testing Market
16.1 Market Share by Country
16.2 Saudi Arabia
16.3 United Arab Emirates
16.4 Nigeria
16.5 South Africa
16.6 Others
17 Patent Analysis
17.1 Analysis by Type of Patent
17.2 Analysis by Publication year
17.3 Analysis by Issuing Authority
17.4 Analysis by Patent Age
17.5 Analysis by CPC Analysis
17.6 Analysis by Patent Valuation
17.7 Analysis by Key Players
18 Grants Analysis
18.1 Analysis by year
18.2 Analysis by Amount Awarded
18.3 Analysis by Issuing Authority
18.4 Analysis by Grant Application
18.5 Analysis by Funding Institute
18.6 Analysis by NIH Departments
18.7 Analysis by Recipient Organization
19 Clinical Trials Analysis
19.1 Analysis by Trial Registration Year
19.2 Analysis by Trial Status
19.3 Analysis by Trial Phase
19.4 Analysis by Therapeutic Area
19.5 Analysis by Geography
20 Funding Analysis
20.1 Analysis by Funding Instances
20.2 Analysis by Type of Funding
20.3 Analysis by Funding Amount
20.4 Analysis by Leading Players
20.5 Analysis by Leading Investors
20.6 Analysis by Geography
21 Partnership and Collaborations Analysis
21.1 Analysis by Partnership Instances
21.2 Analysis by Type of Partnership
21.3 Analysis by Leading Players
21.4 Analysis by Geography
22 Regulatory Framework
22.1 Regulatory Overview
22.1.1 US FDA
22.1.2 EU EMA
22.1.3 INDIA CDSCO
22.1.4 JAPAN PMDA
22.1.5 Others
23 Supplier Landscape
23.1 Abbott Laboratories
23.1.1 Financial Analysis
23.1.2 Product Portfolio
23.1.3 Demographic Reach and Achievements
23.1.4 Mergers and Acquisitions
23.1.5 Certifications
23.2 Alere Inc.
23.2.1 Financial Analysis
23.2.2 Product Portfolio
23.2.3 Demographic Reach and Achievements
23.2.4 Mergers and Acquisitions
23.2.5 Certifications
23.3 Becton, Dickinson and Company (BD)
23.3.1 Financial Analysis
23.3.2 Product Portfolio
23.3.3 Demographic Reach and Achievements
23.3.4 Mergers and Acquisitions
23.3.5 Certifications
23.4 Bio-Rad Laboratories, Inc.
23.4.1 Financial Analysis
23.4.2 Product Portfolio
23.4.3 Demographic Reach and Achievements
23.4.4 Mergers and Acquisitions
23.4.5 Certifications
23.5 bioMerieux S.A.
23.5.1 Financial Analysis
23.5.2 Product Portfolio
23.5.3 Demographic Reach and Achievements
23.5.4 Mergers and Acquisitions
23.5.5 Certifications
23.6 Beckman Coulter, Inc.
23.6.1 Financial Analysis
23.6.2 Product Portfolio
23.6.3 Demographic Reach and Achievements
23.6.4 Mergers and Acquisitions
23.6.5 Certifications
23.7 Eiken Chemical Co., Ltd
23.7.1 Financial Analysis
23.7.2 Product Portfolio
23.7.3 Demographic Reach and Achievements
23.7.4 Mergers and Acquisitions
23.7.5 Certifications
23.8 Hologic, Inc.
23.8.1 Financial Analysis
23.8.2 Product Portfolio
23.8.3 Demographic Reach and Achievements
23.8.4 Mergers and Acquisitions
23.8.5 Certifications
23.9 Pro-lab Diagnostics, Inc.
23.9.1 Financial Analysis
23.9.2 Product Portfolio
23.9.3 Demographic Reach and Achievements
23.9.4 Mergers and Acquisitions
23.9.5 Certifications
23.10 QIAGEN
23.10.1 Financial Analysis
23.10.2 Product Portfolio
23.10.3 Demographic Reach and Achievements
23.10.4 Mergers and Acquisitions
23.10.5 Certifications
23.11 Roche Diagnostics
23.11.1 Financial Analysis
23.11.2 Product Portfolio
23.11.3 Demographic Reach and Achievements
23.11.4 Mergers and Acquisitions
23.11.5 Certifications
23.12 Takara Bio, Inc.
23.12.1 Financial Analysis
23.12.2 Product Portfolio
23.12.3 Demographic Reach and Achievements
23.12.4 Mergers and Acquisitions
23.12.5 Certifications
23.13 Thermo Fischer Scientific, Inc.
23.13.1 Financial Analysis
23.13.2 Product Portfolio
23.13.3 Demographic Reach and Achievements
23.13.4 Mergers and Acquisitions
23.13.5 Certifications
24 Global Legionella Testing Market- Distribution Model (Additional Insight)
24.1 Overview
24.2 Potential Distributors
24.3 Key Parameters for Distribution Partner Assessment
25 Key Opinion Leaders (KOL) Insights (Additional Insight)
26 Company Competitiveness Analysis (Additional Insight)
26.1 Very Small Companies
26.2 Small Companies
26.3 Mid-Sized Companies
26.4 Large Companies
26.5 Very Large Companies
27 Payment Methods (Additional Insight)
27.1 Government Funded
27.2 Private Insurance
27.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
In 2022, the market attained a value of nearly USD 288.1 million.
The market is expected to grow at a CAGR of 8.20% from 2023 to 2031 to reach a value of USD 585.6 million by 2031.
The market is being driven by the growing prevalence of legionella outbreaks in buildings, the increasing concerns regarding Legionnaires’ disease during the COVID-19 pandemic, and the stagnancy of potable water due to prolonged shutdowns of buildings and manufacturing facilities amidst the coronavirus crisis.
The industry is projected to be propelled by the growing prevalence of waterborne diseases, the rising demand for managing potable water, and the introduction of various government initiatives to prevent the risk of legionella outbreaks.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The major application segments of legionella testing in the industry are water testing and IVD testing.
The major players in the industry are Abbott Laboratories, Alere Inc., Becton, Dickinson and Company (BD), Bio-Rad Laboratories, Inc., and bioMerieux S.A., among others.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$ 3499
$1999
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$5999$2999-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
$7999$3999-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$9999$5999-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER